P0146 : Oral, once-daily, cenicriviroc leads to rapid and potent CCR2 and CCR5 blockade in subjects with advanced liver disease, similar to effects seen in healthy volunteers and HIV-1 infected subjects.
Saved in:
| Title: | P0146 : Oral, once-daily, cenicriviroc leads to rapid and potent CCR2 and CCR5 blockade in subjects with advanced liver disease, similar to effects seen in healthy volunteers and HIV-1 infected subjects. |
|---|---|
| Authors: | Utay, N.S.1 neutay@UTMB.EDU, Gottwald, M.2, Chang, W.2, Willett, M.S.3, Lefebvre, E.2 |
| Source: | Journal of Hepatology. Apr2015 Supplement 2, Vol. 62, pS356-S357. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01688278 |
|---|---|
| DOI: | 10.1016/S0168-8278(15)30366-4 |
